| 000 | 01023 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516034044.0 | ||
| 264 | 0 | _c20110930 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1944-7930 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPariser, Anne R | |
| 245 | 0 | 0 |
_aRegulatory considerations for developing drugs for rare diseases: orphan designations and early phase clinical trials. _h[electronic resource] |
| 260 |
_bDiscovery medicine _cApr 2011 |
||
| 300 |
_a367-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug Discovery _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLegislation, Drug |
| 650 | 0 | 4 |
_aOrphan Drug Production _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aRare Diseases _xdrug therapy |
| 700 | 1 | _aXu, Kui | |
| 700 | 1 | _aMilto, John | |
| 700 | 1 | _aCoté, Timothy R | |
| 773 | 0 |
_tDiscovery medicine _gvol. 11 _gno. 59 _gp. 367-75 |
|
| 999 |
_c20789093 _d20789093 |
||